Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cellebrite DI (CLBT)
NASDAQ:CLBT
Holding CLBT?
Track your performance easily
CLBT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.29 - $23.50
Previous CloseN/A
Volume262.11K
Average Volume (3M)1.14M
Market Cap
$4.78B
Enterprise Value$3.16B
Total Cash (Recent Filing)$237.64M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Feb 13, 2025EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.55
Shares Outstanding208,081,800
10 Day Avg. Volume1,433,214
30 Day Avg. Volume1,137,628
Standard Deviation0.15
R-Squared0.28
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)15.47
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue23.51
Enterprise Value/Gross Profit11.61
Enterprise Value/Ebitda-1.49K
Forecast
1Y Price Target
$23.00Price Target Upside0.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Cellebrite DI News
PremiumCompany Announcements
Cellebrite Strengthens Board with New Appointments for 2025 Growth
Bulls Say, Bears Say
Bulls Say
Customer EngagementCellebrite is benefiting from its existing customer base buying more products as NRR remained strong at 124%.
Product AdoptionThe company's C2C solution is seeing positive traction from customers as they seek to digitize their forensic and investigative capabilities.
Revenue GrowthCellebrite's revenue beat consensus after adjusting for lower-quality, non-recurring Professional Services.
Bears Say
Execution RiskThe announcement regarding CEO Yossi Carmil's departure weighs on shares due to questions about timing and the lack of an overlapping transition period, introducing potential execution risk.
Financial PerformanceManagement acknowledged that the margin expansion has been stronger than expected but conveyed that the rate of expansion should moderate as investments increase.
Leadership ChangeSome of the sell-off may be related to the announced departure of long-time CEO Yossi Carmil.
---
Ownership Overview
―
Insiders
2.51% Mutual Funds
0.14% Other Institutional Investors
96.58% Public Companies and Individual Investors
CLBT FAQ
What was Cellebrite DI’s price range in the past 12 months?
Cellebrite DI lowest stock price was $8.29 and its highest was $23.50 in the past 12 months.
What is Cellebrite DI’s market cap?
Cellebrite DI’s market cap is $4.78B.
When is Cellebrite DI’s upcoming earnings report date?
Cellebrite DI’s upcoming earnings report date is Feb 13, 2025 which is in 26 days.
How were Cellebrite DI’s earnings last quarter?
Cellebrite DI released its earnings results on Nov 06, 2024. The company reported -$0.99 earnings per share for the quarter, missing the consensus estimate of $0.075 by -$1.065.
Is Cellebrite DI overvalued?
According to Wall Street analysts Cellebrite DI’s price is currently Undervalued.
Does Cellebrite DI pay dividends?
Cellebrite DI does not currently pay dividends.
What is Cellebrite DI’s EPS estimate?
Cellebrite DI’s EPS estimate is 0.06.
How many shares outstanding does Cellebrite DI have?
Cellebrite DI has 208,081,800 shares outstanding.
What happened to Cellebrite DI’s price movement after its last earnings report?
Cellebrite DI reported an EPS of -$0.99 in its last earnings report, missing expectations of $0.075. Following the earnings report the stock price went down -0.313%.
Which hedge fund is a major shareholder of Cellebrite DI?
Currently, no hedge funds are holding shares in CLBT
---
Cellebrite DI Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.00 (0.97% Upside)
$23.00 (0.97% Upside)
Blogger Sentiment
Bullish
CLBT Sentiment 75%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 406.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 10.3%
Last 30 Days ▲ 10.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
176.79%
12-Months-Change
Fundamentals
Return on Equity
-188.50%
Trailing 12-Months
Asset Growth
31.93%
Trailing 12-Months
Company Description
Cellebrite DI
Cellebrite offers digital intelligence solutions. Its platform and solutions help law enforcement agencies (police departments, armed services, public defenders, start departments) and enterprise customers to better collect, review, analyze, and manage digital data in legally sanctioned investigations.
---
CLBT Company Deck
---
CLBT Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Cellebrite delivered a strong financial performance in Q3 2024, with record revenue and ARR growth, high profitability, and significant expansion in the federal sector. The announcement of the CEO transition introduces some uncertainty but does not outweigh the positive financial and operational achievements.Read More>---
CLBT Stock 12 Month Forecast
Average Price Target
$23.00
▲(0.97% Upside)
Technical Analysis
CrowdStrike Holdings
―
Varonis Systems
―
Tenable Holdings
―
Qualys
―
SentinelOne
―
Zscaler
―
Best Analysts Covering CLBT
1 Year
1 Year Success Rate
17/18 ratings generated profit
1 Year Average Return
+84.01%
reiterated a buy rating 12 days ago
Copying Jeff Van Rhee's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +84.01% per trade.
---